A PYMNTS Company

US: Pharma transaction leads to takeover speculation

By  |  February 11, 2013

Pharmaceutical giant Regeneron Pharmaceuticals Inc has announced its drug-development ally Sanofi SA plans to increase its stock in the pharma company through a 5.3 percent purchase. In a statement, Sanofi said it is allowed to build its stock in Regeneron to up to 30 percent; Sanofi controls 16.7 percent currently, according to reports. Sanofi also denied speculation that the company is going after a controlling stake in the pharmaceutical company. The two have a longstanding partnership in drug development.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

     

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.